Omeros (OMER) Research & Development (2010 - 2026)
Omeros (OMER) reported Research & Development of $13.8 million for Q2 2026, down 37.3% from $22.01 million a year earlier but up 3.3% from the prior quarter.
Powered by 
Analysis
Omeros (OMER) Research & Development (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Omeros' Research & Development came in at $62.6 million, down 32.9% year-over-year; for FY2025, it came in at $81.3 million, down 32.0% from FY2024.
- Research & Development has a five-year compound annual growth rate of -5.5% (FY2020 to FY2025).
- By year, Research & Development came in at $119.52 million in FY2024 (+4.1%), $114.87 million in FY2023 (+1.9%), $112.72 million in FY2022 (-5.1%) and $118.78 million in FY2021 (+10.4%).
- Five-year quarterly Research & Development spans a low of $13.36 million in Q1 2026 and a high of $45.35 million in Q2 2024.
- Year over year, Research & Development has now declined in each of the last eight quarters, with an average decline of 29.7% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q2 2024 (growth of 53.0%); the low point was Q2 2025 (a decline of 51.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $13.36 million (Q1 2026), $19.45 million (Q4 2025) and $16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Omeros | 1.40 Bn | 1.40 Bn | 27.73 Mn | 13.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.80 Mn |
| Mar 31, 2026 | 13.36 Mn |
| Dec 31, 2025 | 19.45 Mn |
| Sep 30, 2025 | 16.00 Mn |
| Jun 30, 2025 | 22.01 Mn |
| Mar 31, 2025 | 23.85 Mn |
| Dec 31, 2024 | 23.32 Mn |
| Sep 30, 2024 | 24.08 Mn |
| Jun 30, 2024 | 45.35 Mn |
| Mar 31, 2024 | 26.77 Mn |
| Dec 31, 2023 | 28.89 Mn |
| Sep 30, 2023 | 31.73 Mn |
| Jun 30, 2023 | 29.64 Mn |
| Mar 31, 2023 | 24.61 Mn |
| Dec 31, 2022 | 26.55 Mn |
| Sep 30, 2022 | 38.57 Mn |
| Jun 30, 2022 | 23.52 Mn |
| Mar 31, 2022 | 24.09 Mn |
| Dec 31, 2021 | 30.33 Mn |
| Sep 30, 2021 | 25.82 Mn |
API Access
Omeros Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=OMER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "OMER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=OMER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();